Fundraising Fox
One Zyme
Founded 2025 · 7 employees on LinkedIn · 5 known investors
Find your way into One Zyme
Sign up to see every warm intro you have to One Zyme
- Paths you didn't know you had: your email and LinkedIn already hold routes to the One Zyme team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
One Zyme is an AI-native intelligence platform that aggregates scientific, clinical, regulatory, funding, patent, deal, and conference signals into a shared knowledge graph for life sciences teams. It provides AI agents and nine intelligence workflows serving business development, competitive intelligence, R&D, commercial, and biopharma vendor teams across the pharma and biotech industry.
Founders & leadership
One Zyme was founded in 2025 by Aaron Michel.
Investors · 5
How we know: Esplanade Ventures's portfolio page · Not right? Tell us
How we know: Newfund Capital's portfolio page · Not right? Tell us
How we know: Service Provider Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does One Zyme do?
- One Zyme is an AI-native intelligence platform that aggregates scientific, clinical, regulatory, funding, patent, deal, and conference signals into a shared knowledge graph for life sciences teams. It provides AI agents and nine intelligence workflows serving business development, competitive intelligence, R&D, commercial, and biopharma vendor teams across the pharma and biotech industry.
- Who founded One Zyme?
- One Zyme was founded by Aaron Michel in 2025.
- Who are One Zyme's investors?
- One Zyme's investors include Esplanade Ventures, Invariantes Fund, Newfund Capital, Service Provider Capital, TMV.